Search results
Results From The WOW.Com Content Network
Alphos (from Greek ἀλφός alphos "a dull white leprosy") is a form of non-contagious leprosy, formerly described by the physician Celsus under the name of vitiligo, a term now used for another skin disease. In alphos, the skin is rough, and looks as if it had drops of white on it, not much differing from morphea.
Tzaraath (Hebrew: צָרַעַת ṣāraʿaṯ), variously transcribed into English and frequently translated as leprosy (though it is not Hansen's disease, the disease known as "leprosy" in modern times [1]), is a term used in the Bible to describe various ritually impure disfigurative conditions of the human skin, [2] clothing, [3] and ...
Leprosy has historically been associated with social stigma, which continues to be a barrier to self-reporting and early treatment. [4] Leprosy is classified as a neglected tropical disease. [21] World Leprosy Day was started in 1954 to draw awareness to those affected by leprosy. [22] [4] The study of leprosy and its treatment is known as ...
Spinalonga on Crete, Greece, one of the last leprosy colonies in Europe, closed in 1957. A leper colony, also known by many other names, is an isolated community for the quarantining and treatment of lepers, people suffering from leprosy.
Gehazi was the servant of the prophet Elisha.He appears in connection with the history of the Shunammite woman and her son [2] and of Naaman the Syrian. On the latter occasion, Gehazi, overcome with avarice, obtained in the prophet's name two talents of silver and two valuable robes from Naaman.
The Latin word Alpes could possibly come from the adjective albus [7] ("white"), or could possibly come from the Greek goddess Alphito, whose name is related to alphita, the "white flour"; alphos, a dull white leprosy; and finally the Proto-Indo-European word *albʰós.
Mycobacterium leprae (also known as the leprosy bacillus or Hansen's bacillus) is one [a] of the two species of bacteria that cause Hansen's disease (leprosy), [1] a chronic but curable infectious disease that damages the peripheral nerves and targets the skin, eyes, nose, and muscles.
The diffuse leprosy of Lucio and Latapí, also known as diffuse lepromatous leprosy or "pretty leprosy", is a clinical variety of lepromatous leprosy. It was first described by Lucio and Alvarado in 1852 and re-identified by Latapí in 1936. It is common in Mexico (23% of leprosy cases) and in Costa Rica and very rare in other countries.